Such-Lupe

FAQs

STADA's earnings in recent years

Operating profit, EBITDA (earnings before interest, taxes, depreciation and amortization), EBIT (earnings before interest and taxes), EBT (earnings before taxes), the net income, the earnings per share and the diluted earnings per share (EPS diluted) for the last five financial years are shown the following table.

Financial key figures in EUR million
1) The accounting treatment of shareholdings in BIOCEUTICALS Arzneimittel AG was changed retroactively for the years 2007 to 2001. For reasons of the practicability caveat as specified under IAS 8.43 ff., the comparison figures and the key figures for the 2006 to 2001 period were not adapted. Therefore, disclosures made in the Annual Report 2010 for financial years 2006 and before do not include the recognition of BIOCEUTICALS Arzneimittel AG as an associated company under the equity method.
2) Adjustment for the one-time special effects as well as effects from currency influences and interest rate hedge transactions respectively incurred.
Back Forward

 

(c) 2012 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de